UKOM Sp.F.M study materials
UKOM Sp.F.M study resources

UKOM Sp.F.M cheat sheet

UKOM Sp.F.M · Keep the key ideas within reach.

Quick reference

Pharmacy Management and Leadership

  • Management functions: planning, organizing, staffing, directing, controlling - each maps to a distinct set of managerial activities and measurable outputs.

  • Leadership styles: autocratic (fast, low buy-in), democratic (slower, higher commitment), laissez-faire (effective only with expert, self-directed staff), transformational (vision-driven change).

  • Span of control: narrow spans suit complex, high-risk work such as sterile compounding; wide spans suit routine, standardized tasks.

  • SMART objectives: Specific, Measurable, Achievable, Relevant, Time-bound; vague goals cannot be monitored or evaluated.

  • Delegation rule: authority and accountability transfer, but final responsibility to the license holder does not.

  • Change management sequence: unfreeze, change, refreeze; skipping unfreezing produces relapse to prior practice.

  • Key performance indicators should be few, linked to strategy, and balanced across clinical quality, safety, finance, and workforce.

  • Conflict modes per Thomas-Kilmann: competing, collaborating, compromising, avoiding, accommodating; collaborating suits interdependent pharmacy teams.

Quick reference

Pharmacy Economics and Health Financing

  • Gross margin = revenue − cost of goods sold; gross margin % = gross margin ÷ revenue × 100.

  • Markup is calculated on cost; margin is calculated on selling price - markup % always exceeds the equivalent margin %.

  • Break-even volume = fixed costs ÷ (unit price − unit variable cost); break-even revenue = fixed costs ÷ contribution margin ratio.

  • Contribution margin per unit = selling price − variable cost per unit; it funds fixed costs first, then profit.

  • Cost-effectiveness ratio (ICER) = (cost A − cost B) ÷ (effect A − effect B); compare against an explicit willingness-to-pay threshold.

  • Financing models: out-of-pocket, social health insurance, private insurance, tax-funded national health service; each shifts risk differently.

  • Inventory carrying cost typically bundles capital cost, storage, insurance, obsolescence, and shrinkage; it is often understated.

  • Sunk costs are irrelevant to forward decisions; incremental (marginal) cost and benefit drive the correct choice.

Quick reference

Pharmacy Business Planning and Entrepreneurship

  • Business plan core sections: executive summary, market analysis, operations, marketing, management, financial projections, risk assessment.

  • Market sizing: TAM (total addressable), SAM (serviceable addressable), SOM (serviceable obtainable) - projections should rest on SOM, not TAM.

  • Cash flow statement differs from profit and loss: it tracks timing of cash in and out, and timing kills otherwise profitable ventures.

  • Payback period = initial investment ÷ annual net cash inflow; shorter is preferred but ignores cash flows after payback.

  • Net present value discounts future cash flows at the cost of capital; NPV > 0 signals value creation, and it is preferred over IRR for ranking.

  • SWOT items should be external (opportunities, threats) versus internal (strengths, weaknesses); misclassification is a common planning error.

  • Location decision criteria: catchment population, prescriber density, competitor saturation, rent per square metre, accessibility, and parking.

  • Pricing strategy options: cost-plus, value-based, competitive, and penetration - penetration pricing trades margin for volume and share.

Quick reference

Human Resource Management in Pharmacy

  • Job analysis produces the job description (tasks, duties) and person specification (qualifications, competencies); recruitment flows from both.

  • Competency frameworks separate technical competencies (dispensing accuracy, clinical knowledge) from behavioral ones (communication, teamwork).

  • Workforce planning formula: required full-time equivalents = total workload hours ÷ productive hours per FTE.

  • Absence rate = days lost ÷ (headcount × working days) × 100; a rising rate is an early attrition signal.

  • Training evaluation per Kirkpatrick: reaction, learning, behavior, results - only the last two demonstrate workplace impact.

  • Performance appraisal should combine results (objectives) and behaviors (competencies); results-only appraisal rewards the wrong conduct.

  • Disciplinary process requires documented due process: clear policy, notice of allegations, opportunity to respond, proportionate sanction, appeal.

  • Turnover cost includes recruitment, induction, lost productivity, and temporary cover - often 50–200% of annual salary for professional roles.

Quick reference

Inventory, Procurement, and Supply Chain Management

  • Economic order quantity (EOQ) = √(2DS ÷ H), where D = annual demand, S = ordering cost per order, H = holding cost per unit per year.

  • Reorder point = (average daily demand × lead time in days) + safety stock.

  • Safety stock rises with demand variability, lead-time variability, and target service level; it falls when suppliers become reliable.

  • ABC analysis by annual consumption value: A items are few but high value and need tight control; C items are many and low value and can use simple rules.

  • FEFO (first-expiry-first-out) governs medicines; FIFO is insufficient because receipt order does not equal expiry order.

  • Cold chain requires validated storage, continuous temperature monitoring, excursion documentation, and quarantine before disposition decisions.

  • Procurement cycle: need identification, specification, supplier selection, contracting, ordering, receipt and inspection, payment, and performance review.

  • Stockout cost includes substitution, delayed therapy, emergency purchases at premium prices, and reputational harm - not just lost sales.

Quick reference

Pharmacy Information Systems and Digital Health

  • Clinical decision support fires alerts on rules (dose range, interaction, allergy, duplicate therapy); excessive alerts cause alert fatigue and override behavior.

  • Computerized provider order entry reduces transcription errors but introduces wrong-patient and wrong-dose selection errors.

  • Barcode medication administration verifies the five rights at the point of administration; workarounds nullify the safety benefit.

  • Data protection principles: lawful basis, purpose limitation, data minimization, accuracy, storage limitation, integrity and confidentiality, accountability.

  • Interoperability standards: HL7 for messaging, FHIR for modern application programming interfaces, and standardized terminologies (SNOMED CT, ICD, ATC) for meaning.

  • System validation follows a lifecycle: user requirements, functional specification, risk assessment, IQ/OQ/PQ testing, and change control.

  • Telepharmacy requires identity verification, secure communication channels, documented consent, and a defined escalation route to in-person care.

  • Downtime planning: documented paper fallback procedures, regular drills, and reconciliation of records after system restoration.

Quick reference

Pharmacy Quality Management and Patient Safety

  • Donabedian model: structure (resources), process (what is done), outcome (what results) - measure all three, not outcomes alone.

  • Plan-Do-Study-Act cycles drive iterative improvement; a single cycle is a test, not proof, so multiple cycles are needed.

  • Root cause analysis follows the event: secure the scene, gather facts, map causal factors, identify system failures, then design and monitor actions.

  • Medication error severity scales classify near misses separately from harm events; near-miss reporting is the leading indicator of safety culture.

  • Ishikawa (fishbone) categories: people, process, equipment, environment, materials, management - used to structure cause analysis.

  • Control chart interpretation: a run of seven or more points on one side of the mean signals special-cause variation requiring investigation.

  • Sterile compounding quality requires environmental monitoring, media fill validation, operator qualification, and documented cleaning schedules.

  • Audit cycle: define standards, collect data, compare against standard, implement change, re-audit to confirm improvement and sustain it.

Quick reference

Pharmacy Regulation, Ethics, and Professional Standards

  • Ethical principles: beneficence, non-maleficence, autonomy, justice - conflicts between them must be reasoned, not assumed away.

  • Informed consent requires capacity, adequate disclosure, comprehension, and voluntariness; a signature alone does not prove consent.

  • Confidentiality may be breached only where law or serious public interest requires it, and disclosure should be minimal and documented.

  • Professional boundaries: personal or financial relationships with patients create conflicts of interest that must be declared and avoided.

  • Record retention and record quality: contemporaneous, legible, attributable entries; retrospective alteration of records is misconduct.

  • Scope of practice: competence plus authorization; working outside competence, even with good intent, is a fitness-to-practice risk.

  • Duty to report: impaired colleagues, serious safety incidents, and suspected diversion of controlled drugs trigger mandatory escalation.

  • Pharmacovigilance obligations: report suspected adverse drug reactions through the national scheme, including for vaccines and biologics.

Quick reference

Health Policy and National Pharmacy Programs

  • Universal health coverage dimensions: population covered, services covered, and proportion of costs covered - expansion along one axis without the others is incomplete.

  • Essential medicines list logic: efficacy, safety, comparative cost-effectiveness, and public health need determine inclusion, not brand preference.

  • Reimbursement mechanisms: cost-plus, reference pricing, tendering, and external price referencing each shift incentive between payer and provider.

  • Pharmaceutical benefit schemes commonly use copayment tiers, deductibles, and prior authorization to manage expenditure.

  • National medicines policy pillars: selection, affordability, financing, supply systems, regulation and quality assurance, rational use, and human resources.

  • Antimicrobial stewardship is a national policy priority: prescribing restrictions, surveillance, and public awareness operate together.

  • Pharmacist-delivered services (vaccination, smoking cessation, medication review) require an explicit funding pathway to be sustainable.

  • Health technology assessment informs coverage decisions using clinical effectiveness, cost-effectiveness, budget impact, and equity considerations.

Quick reference

Pharmacy Practice Management in Hospital and Community Settings

  • Hospital pharmacy workflow: prescribing, verification, dispensing, administration, and monitoring; each handoff is an error-prone step.

  • Medication reconciliation at admission, transfer, and discharge prevents unintended discrepancies; it is a process, not a single form.

  • Unit dose distribution reduces preparation errors and waste compared with bulk ward stock, at higher distribution cost.

  • Community pharmacy layout: prescription reception, dispensing and checking zone, consultation room, and self-selection area should be physically separated.

  • Skill-mix design: technicians handle dispensing and stock tasks under supervision; pharmacists focus on clinical review and counseling.

  • Queue management: reducing waiting time requires matching capacity to arrival patterns, not simply adding staff at peak.

  • Medication review focuses on indication, effectiveness, safety, adherence, and cost; deprescribing is a legitimate outcome.

  • Service capacity formula: appointments available = staff hours × utilization ÷ average minutes per appointment.